Physicians, researchers and computation scientists used patient genomic sequencing and CNV data generated by Otogenetics in a clinical trial for identification of effective biological pathway targets unique to each individual cancer patient who had failed traditional treatment(s). The mathematical model…
Author: admin
Somatic activating mutations in MAP2K1 cause melorheostosis
Deep Exome Sequencing by Otogenetics for Clinical Researchers leads to discovery of key somatic mutations in MAP2K1 in melorheostotic* bones of patients. (*Melorheosis is characterized by excess bone formation on the surface of the bone. The bone overgrowth lesions are…
Otogenetics helps clinicians in discovery of a novel autosomal dominant hearing loss mutation
Otogenetics hearing loss gene test lend the tool for clinicians to discover an autosomal dominant hearing loss mutation in POU4F3 gene. This particular variant t cosegregated with hearing loss in family members but was not detected in 580 normal hearing…
Cancer Marker Identification Using Otogenetics NGS Service
Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice Read the full article here
Otogenetics Helps Educating a New Generation of Medical Students with Cadaver Exome Sequencing.
US life expectancy varies > 20 years regionally. Access to quality healthcare, such as early cancer screening, is a contributing factor. Check out the new study published in JAMA Internal Medicine (May 8, 2017), and check out Gx™ cancer genetic screening.
Early Cancer Screen is Associated Positively with Life Expectancy.
Gx™ Inherited Cancer Gene Testing (Gx™ InhCa) Analyzes 39 genes linked to breast, ovarian, colorectal, pancreatic, and other major types of cancers Early cancer screen contributes to greatly increased life expectancy in the US, according to a recent report in…